2024 Industry-Sponsored Conference Events - NAPNAP

2024 Industry-Sponsored Conference Events

Free CE Symposium and Non-CE Product Theater Meal Events and Exhibit Hall Product Showcase

All of these CE and non-CE educational opportunities are sponsored by companies with a focus on children’s health. Pre-registration is not required. Sponsoring companies will admit attendees on a space available basis. Don’t miss out!

Wednesday, March 13

Xolair: A Therapeutic Option for IgE-Mediated Food Allergies
Abby Allen, DRNP
American Academy of Nurse Practitioners (AANP certified)
Master of Science of Nursing, Wilmington University
Certified Family Nurse Practitioner with 14 years of direct patient care experience in the Asthma, Allergy & Immunology Specialty
12:15-1:30 p.m. Lunch and Presentation
Colorado Convention Center, Four Seasons Ballroom 4, Ballroom Level
This Non-CE lunch product theater is sponsored by Genentech, Inc.

Recommendations and Strategies to Help Protect Children from Pneumococcal Disease with a Next-Generation Conjugate Vaccine
Laurene Mascola, MD, MPH, FAAP
12:15-1:30 p.m. Lunch and Presentation
Colorado Convention Center, Room 401/402/403, Meeting/Street level
This Non-CE lunch product theater is sponsored by Pfizer.

Thursday, March 14

Update in Food Allergy Management
Lauren Herlihy, DNP, APRN, CPNP
Clinical Assistant Professor, UNC Chapel Hill School of Nursing
Research Instructor, UNC Chapel Hill School of Medicine
Chapel Hill, NC
Brian P. Vickery, MD
Professor of Pediatrics, Marcus Professor of Pediatric Immunology
Chief, Division of Allergy/Immunology, Emory University & Children’s Healthcare of Atlanta
Atlanta, GA
Registration Link: www.bit.ly/NAPNAP24FoodAllergy
Buffet Breakfast: 7:30-8 a.m. 
Symposium: 8-9 a.m.
Colorado Convention Center, Four Seasons Ballroom 4, Ballroom Level   
This CE breakfast symposium is supported by an educational grant from Genentech, a member of the Roche Group.

Partner in Asthma Care, Partner in Asthma Relief
Nicole Chase, MD
Partner, St. Paul Allergy and Asthma, P.A.
St. Paul, MN
12:30-1:45 p.m. Lunch and Presentation
Colorado Convention Center, Four Seasons Ballroom 4, Ballroom Level  
This Non-CE lunch product theater is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

Treatment Update: The First FDA-approved Treatment for Molluscum Contagiosum
Samantha Casselman, DNP, CPNP-PC
12:30-1:45 p.m. Lunch and Presentation
Colorado Convention Center, Room 401/402/403, Meeting/Street level
This Non-CE lunch product theater is sponsored by Verrica Pharmaceuticals Inc.

Friday, March 15

Diagnosing Metabolic Bone Disorders: A Guide About XLH for the Multidisciplinary Team
Courtney Reints, DNP, ARNP, CPNP-PC
7:30-9 a.m. Breakfast and Presentation
Colorado Convention Center, Four Seasons Ballroom 4, Ballroom Level   
This Non-CE breakfast product theater is sponsored by Kyowa Kirin.

The Flu Ends with U: The Nurse’s Impact
Mike Robinson, DNP, FNP-C
Audrey Stevenson, PhD, MPH, MSN, FNP-BC
11:40 a.m.-1 p.m. Lunch and Presentation
Colorado Convention Center, Four Seasons Ballroom 4, Ballroom Level 
This Non-CE lunch product theater is sponsored by CSL Seqirus.

Key Concepts in Atopic Dermatitis: A Collaborative Approach to Diagnosis, Management, and Control
Leigh Ann Pansch, MSN, FNP-BC, DCNP
Dermatology Nurse Practitioner
Director for NP/PA Education, Dermatologists of Central States
Cincinnati, Ohio
Come learn about key concepts in atopic dermatitis (AD) and explore a collaborative approach to diagnosis, management, and control. Also, learn about a treatment option that may help appropriate patients with uncontrolled moderate-to-severe AD.
11:40 a.m.-1 p.m. Lunch and Presentation
Colorado Convention Center, Room 401/402/403, Meeting/Street level
This Non-CE lunch product theater is sponsored by Sanofi and Regeneron Pharmaceuticals, Inc.

This product showcase will take place in the Colorado Convention Center, Exhibit Hall A. No pre-registration is required.

Wednesday, March 13

Addressing Pediatric Skincare Conditions from Infant to Adolescent
12:45-1:15 p.m.
NAPNAP Exhibit Hall A
This product showcase is sponsored by CeraVe®.

All industry-sponsored posters will be displayed in the exhibit hall at the Colorado Convention Center, Exhibit Hall A during exhibit hours. Presenters will be available for questions on Wednesday, March 13 from 6-7 p.m. Note: CE credit will NOT be given for the industry-sponsored posters.

Poster #1: Glycemic outcomes in youth-onset T2D with and without background insulin therapy: post hoc analysis of the DINAMO trial of empagliflozin vs. placebo and linagliptin vs. placebo
Presented by: Dr. Steven Willi
Poster sponsored by: Boehringer Ingelheim & Eli Lilly and Company Diabetes Alliance      

Poster #2: Effect of Upper Respiratory Tract Infection on the Pharmacokinetics of Intranasal Epinephrine (ARS-1)
Presented by: Ayman Kafal, PhD
Poster sponsored by ARS Pharmaceuticals, Inc.  

Poster #3: A Single-Period, Single-Dose Study of the Pharmacokinetics of Epinephrine After Administration of ARS-1 to Pediatric Subjects
Presented by: Christopher Dietrich
Poster sponsored by: ARS Pharmaceuticals, Inc.

Poster #4: Association Between Baseline Characteristics and Oral Corticosteroid Elimination in Patients With Oral Corticosteroid-Dependent Severe Asthma
Presented by: Leslie Coons
Poster sponsored by: Sanofi Regeneron 

Poster #5: Dupilumab long term Efficacy in Children With/Without Allergic Asthma in the Presence of Elevated Type 2 Biomarkers
Presented by: Leslie Coons
Poster sponsored by: Sanofi Regeneron 

Poster #6: Coexisting Chronic Rhinosinusitis with Nasal Polyps in Patients With Moderate-to-Severe Asthma: The RAPID registry study
Presented by: Leslie Coons
Poster sponsored by: Sanofi Regeneron 

Poster #7: Baseline demographics and disease characteristics of paediatric patients with eosinophilic esophagitis (EoE) from the randomised, placebo-controlled, phase 3 EoE KIDS study
Presented by: Golnar Vazirabad
Poster sponsored by: Sanofi Regeneron 

Poster #8: Dupilumab improves histologic and endoscopic aspects of eosinophilic esophagitis (EoE), as well as rate of weight gain, in children aged 1 to <12 years: 52-week results from the Phase 3 EoE KIDS trial
Presented by: Golnar Vazirabad
Poster sponsored by: Sanofi Regeneron

Poster #9: Dupilumab Treatment Shows Rapid and Consistent Improvement in Atopic Dermatitis in All Anatomical Regions in Patients Aged 6 Months to 17 Years: Results From an Open-Label Extension Study
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron 

Poster #10: Dupilumab Treatment Provides Long-Term Disease Control in Paediatric Patients With Moderate-to-Severe Atopic Dermatitis Over 1 Year 
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron 

Poster #11: Dupilumab significantly improves patient reported outcomes in pediatric AD patients less than 12 years of age
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron 

Poster #12: Dupilumab Treatment Results in Rapid, Sustained and Clinically Meaningful Improvement in Itch in Patients Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron 

Poster #13: Real-World Effectiveness of Dupilumab in Adult and Adolescent Patients With Atopic Dermatitis: 3-Year Data From the PROSE Registry
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron

Poster #14: Dupilumab treatment reduces signs and symptoms in patients with atopic hand and foot dermatitis: Results from a phase 3, randomized, double-blind, placebo-controlled trial
Presented by: Edith Heydinger
Poster sponsored by: Sanofi Regeneron 

Poster #15: Dupilumab demonstrates greater improvement in disease activity than standard-of-care H1-antihistamines in CSU
Presented by: Edith Heydinger
Poster sponsored by: Sanofi       

Poster #16: Estimated Additional Burden Averted from Use of Cell-Based Influenza Vaccines Compared to Egg-Based Influenza Vaccines Among Children <18 in the United States: 2017-2020 Seasons
Presented by: Sabrina Martinez
Poster sponsored by: CSL Seqirus             

Powered by Americaneagle.com

Website design and development by Americaneagle.com, Inc.